Embolic protection devices in saphenous vein graft interventions

Journal of Interventional Cardiology

Volumn 19, Issue 6, 2006, Pages 525-529

  Cragun, David T ^a   Heuser, Richard R ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Phoenix Heart Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

BALLOON OCCLUSION; BLOOD FILTER; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEVICE; EMBOLISM; GRAFT OCCLUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; SAPHENOUS VEIN GRAFT; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; GRAFT OCCLUSION, VASCULAR; HUMANS; SAPHENOUS VEIN; STENTS;

EID: 33750867233     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2006.00204.x     Document Type: Review

References (13)

1. Bourassa MG, Campeau L, Lesperance J, et al. Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: Results at repeat angiography. Circulation 1982;65:90-97.
2. Goldman S, Zadina K, Moritz T, et al. Prospective ten-year patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery. J Am Coll Cardiol 2001;37(Suppl. A):1A-648A.
3. Hong MK, Mahran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:2400-2405.
4. Webb J, Carerc R, Virmani R, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol 1999;34:468-475.
5. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass graft. Circulation 2002;105:1285-1290.
6. Carrozza J, Mumma M, Breall J, et al. Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol 2005;46:1677-1683.
7. Rogers C. A prospective randomized comparison of proximal and sital protection in patients with diseased saphenous vein grafts [abstract]. Presented at Transcatheter Cardiovascular Therapeutics, October 2005.
8. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003;108:548-553.
9. Grube E, Schofer J, Webb J, et al. for the Saphenous Vein Graft Angioplasty Free of Emboli (SAFE) Trial Study Group. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting and saphenous vein grafts. Am J Cardiol 2002;89:941-945.
10. Rogers R, Huynh R, Seifert P, et al. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation 2004;109:1735-1740.
11. Jonas M, Stone G, Mehran R, et al. Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: Differential effects after randomization to occlusion or filter-based embolic protection. Eur Heart J 2006;27:920-928.
12. Mathew V, Lennon R, Rihal C. Applicability of distal protection for aortocoronary vein graft interventions in clinical practice. Catheter Cardiovasc Interven 2004;63:148-151.
13. Morales P, Heuser R. Guiding catheter aspiration to prevent embolic events during saphenous vein graft intervention. J Interven Cardiol 2002;15:491-498.